Radiation-Guided Targeting of Combretastatin Encapsulated Immunoliposomes to Mammary Tumors |
| |
Authors: | Christopher B. Pattillo Berenice Venegas Fred J. Donelson Luis Del Valle Linda C. Knight Parkson L.-G. Chong Mohammad F. Kiani |
| |
Affiliation: | (1) Department of Mechanical Engineering, Temple University, 1947 N. 12th St., Philadelphia, Pennsylvania 19122, USA;(2) Department of Biochemistry, Temple University School of Medicine, Philadelphia, Pennsylvania, USA;(3) Department of Neuroscience, Temple University School of Medicine, Philadelphia, Pennsylvania, USA;(4) Department of Radiology, Temple University School of Medicine, Philadelphia, Pennsylvania, USA;(5) Department of Radiation Oncology, Temple University School of Medicine, Philadelphia, Pennsylvania, USA; |
| |
Abstract: | Purpose Radiation upregulates expression of endothelial cell adhesion molecules providing a potential avenue for targeting drugs to irradiated tissue. Induced upregulation of E-selectin can be used to target immunoliposomes to solid tumors. The effects of targeting immunoliposomes containing the antivascular drug combretastatin disodium phosphate (CA4P) to irradiated mammary tumors were investigated in this study. Methods Mice bearing transplanted MCa-4 mouse mammary tumors were assigned to one of the factorial treatments permuting the administration of free CA4P, tumor irradiation, CA4P encapsulated liposomes, and CA4P encapsulated immunoliposomes (conjugated with anti-E-selectin). Single and fractionated dosing of radiation and/or CA4P was evaluated. Results For single dose treatments the group that received a single dose of radiation plus a single dose of immunoliposomes showed a significant delay in tumor growth compared to all other treatment groups. Fractionated radiation plus fractionated doses of immunoliposomes resulted in further tumor growth delay; however, it was not significantly different from other fractionated dose treatment groups that combined radiation and CA4P. Conclusions Targeting of antivascular drugs to irradiated tumors via ligand-bearing liposomes results in significant tumor growth delay. This effect can be further potentiated using a fractionated irradiation dosing schedule combined with fractionated immunoliposome treatments. CBP and BV made equal contribution to this work. |
| |
Keywords: | adhesion molecules combretastatin immunoliposomes targeted drug delivery tumor vasculature targeting |
本文献已被 SpringerLink 等数据库收录! |
|